Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen-Reference-Cited by-同舟云学术

Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen

Published:2016-08-08 Issue:1 Volume:16 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Jung Sung-Hoon, ,Cho Min-Seok,Kim Hee Kyung,Kim Seok Jin,Kim Kihyun,Cheong June-Won,Kim Soo-Jeoong,Kim Jin Seok,Ahn Jae-Sook,Kim Yeo-Kyeoung,Yang Deok-Hwan,Kim Hyeoung-Joon,Lee Je-Jung

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-016-2645-y.pdf

Reference29 articles.

1. Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med. 2004;351(18):1860–73.

2. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.

3. Kim K, Lee JH, Kim JS, Min CK, Yoon SS, Shimizu K, Chou T, Kosugi H, Suzuki K, Chen W, et al. Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study. Am J Hematol. 2014;89(7):751–6.

4. Osgood EE. The survival time of patients with plasmocytic myeloma. Cancer Chemother Rep 1. 1960;9:1–10.

5. Barlogie B, Smith L, Alexanian R. Effective treatment of advanced multiple myeloma refractory to alkylating agents. N Engl J Med. 1984;310(21):1353–6.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variation in immunoglobulin use and impact on survival in myeloma;eJHaem;2024-06-16

2. Infecciones en pacientes con diagnóstico reciente de mieloma múltiple: estudio descriptivo unicéntrico de Colombia;CES Medicina;2023-10-27

3. Examining participant representation by sex, race, ethnicity and age in United States blood donation and blood transfusion clinical trials;Transfusion and Apheresis Science;2023-06

4. A real‐world data analysis of predictors of early mortality after a diagnosis of multiple myeloma;Cancer;2023-03-29

5. Eastern Cooperative Oncology Group, β2-microglobulin, hemoglobin, and lactate dehydrogenase can predict early grade ≥ 3 infection in patients with newly diagnosed multiple myeloma: A real-world multicenter study;Frontiers in Microbiology;2023-01-27